Sage Therapeutics Inc. buy Needham & Company LLC
Start price
07.08.23
/
50%
€17.80
Target price
07.08.24
€63.64
Performance (%)
-44.21%
Price
08:55
€9.93
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Sage Therapeutics Inc. is performing very badly with a performance of -44.21%. This prediction currently runs until 07.08.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sage Therapeutics Inc. | -3.181% | -3.181% |
iShares Core DAX® | 1.175% | -0.931% |
iShares Nasdaq 100 | 1.232% | 9.715% |
iShares Nikkei 225® | 1.563% | 3.040% |
iShares S&P 500 | 0.034% | 5.962% |
Comments by Needham___Company_LL for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $70.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat